Issues

In this issue Velagapudi and colleagues (pp. 437–460) highlight a unique way to trigger PARP1 retention on DNA breaks and open a path to unveil the pharmacological benefits of such inhibitors with novel properties. The cover image shows Type I inhibitors modulating PARP1 allostery via different binding poses. The image is courtesy of Tanaji T. Talele.